Ding dong, ding dong (George Harrison)
This is the first issue of 2014, and we wish all who are involved with the Journal of Thrombosis and Haemostasis a good and fruitful New Year. Although prediction is said to be difficult, particularly when it concerns the future, we have little doubt that in 2014 we will receive some 1200 manuscripts, of which we will publish about 300, after a process often involving several rounds of revision. What no one can predict is the content of these papers, and the new findings that will see the light in 2014. The current era in our field is full of hope for more effective and better-designed drugs, both for anticoagulant and hemostatic usage. It is to be expected that in the New Year we will learn more about the (side)-effects of these drugs and which patients will benefit most. For both anticoagulant and hemostatic drugs, standardization of measurements is a major challenge, and we look forward to contributions of the Scientific and Standardization Committee on this. Risk profiling should lead to personalized medicine, in which high-risk patients receive more, and low-risk patients less, or perhaps even no treatment. This is a major challenge, particularly in thrombosis prevention, in which optimization of treatment could prevent both thrombotic and hemorrhagic events. Such risk profiling can only result from a deepened understanding of the mechanisms of disease, for which fundamental research is crucial.
With the start of 2014, several of our Associate Editors retire, and new ones are appointed. We wish to thank Lou Aledort, Marco Cattaneo, Mark Crowther, Sam Machin, Robert Medcalf and Steve Watson, who, for many years have performed this important function for the Journal of Thrombosis and Haemostasis. We are extremely grateful for all their hard work and thank them on behalf of the ISTH. New Associate Editors who join the Journal of Thrombosis and Haemostasis starting this year are Donna DiMichele (USA), Jim Douketis (Canada), Steve Kitchen (UK), Ton Lisman (The Netherlands, on behalf of the International Society for Fibrinolysis and Proteolysis [ISFP]), Diego Mezzano (Chile), and Yukio Ozaki (Japan). These experts span the globe and represent a wide range of expertise, and we are confident that their efforts for the Journal of Thrombosis and Haemostasis will help it to do well in this and subsequent years. However hard Associate Editors, reviewers and production staff may work, the success of the Journal of Thrombosis and Haemostasis will continue to depend on the quality of the manuscripts that are submitted. Therefore, we wish you all a year full of creativity and inspiration that culminates in submissions to the Journal of Thrombosis and Haemostasis.